Vitamin C Pharmacokinetics in Critically Ill Patients
Top Cited Papers
- 6 March 2018
- journal article
- research article
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 153 (6), 1368-1377
- https://doi.org/10.1016/j.chest.2018.02.025
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancerCancer Chemotherapy and Pharmacology, 2013
- An update on primary hyperoxaluriaNature Reviews Nephrology, 2012
- Vitamin C: A Concentration-Function Approach Yields Pharmacology and Therapeutic DiscoveriesAdvances in Nutrition: An International Review Journal, 2011
- Vitamin C-Induced Oxalate NephropathyInternational Journal of Nephrology, 2011
- Ascorbic acid prevents increased endothelial permeability caused by oxidized low density lipoproteinFree Radical Research, 2010
- Oxalic acid excretion after intravenous ascorbic acid administrationMetabolism, 2009
- Mechanism of action of vitamin C in sepsis: Ascorbate modulates redox signaling in endotheliumBioFactors, 2009
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancyAnnals of Oncology, 2008
- Reduction of Resuscitation Fluid Volumes in Severely Burned Patients Using Ascorbic Acid AdministrationArchives of Surgery, 2000
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996